<DOC>
	<DOCNO>NCT00157755</DOCNO>
	<brief_summary>This study evaluate safety effectiveness gastric stimulation reduction nausea vomit patient gastroparesis use approve Humanitarian device . There two cohort study base etiology , one diabetic one idiopathic . A maximum 150 patient ( 75 diabetic 75 idiopathic ) 15 center United States follow closely twelve month year study close . If someone suffering symptom gastroparesis despite try oral medication , may eligible participate clinical study use surgically implant gastric stimulator .</brief_summary>
	<brief_title>Enterra Therapy Clinical Study ( Gastric Stimulation Gastroparesis )</brief_title>
	<detailed_description />
	<mesh_term>Gastroparesis</mesh_term>
	<criteria>Male Female least 18 year age Diagnosed gastroparesis due diabetes unknown cause ( idiopathic ) Have try prokinetic ( help stomach empty quicker ) antiemetic ( help decrease symptom nausea vomit ) medication minimum one month , unless 're unable take type medication Have symptoms gastroparesis require treatment least one year Experience least 7 episode vomit seven consecutive day period 28day diary Willing able completely accurately fill diary questionnaire throughout study Have gastric retention great 10 % four hour , great 60 % two hour ( unable complete fourhour test ) Gastric Emptying Test ( GET ) Gastroparesis cause specific diagnosed illness diabetes Current eat disorder diagnose swallow disorder Previous stomach surgery Taking narcotic painrelievers daily abdominal pain Diagnosed drug alcohol dependency within 1 year study Life expectancy less one year Have implantable device pacemaker Pregnancy plan pregnancy Plan receive diathermy treatment Have radiation therapy upper abdomen Plan MRI perform Currently participate another investigational device drug study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Nausea Vomiting</keyword>
</DOC>